financetom
Business
financetom
/
Business
/
Western Midstream Partners Q1 Net Income, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Western Midstream Partners Q1 Net Income, Revenue Increase
May 8, 2024 2:13 PM

04:46 PM EDT, 05/08/2024 (MT Newswires) -- Western Midstream Partners ( WES ) reported Q1 net income Wednesday of $1.47 per diluted unit, up from $0.52 a year earlier.

Analysts polled by Capital IQ expected $0.79.

Revenue for the quarter ended March 31 was $887.7 million, up from $734 million a year earlier. Analysts surveyed by Capital IQ expected $863.1 million.

The company shares were up 1.9% in recent after-hours activity.

Price: 36.14, Change: +0.64, Percent Change: +1.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
End of Redstone era as Paramount, Skydance Media agree to merge
End of Redstone era as Paramount, Skydance Media agree to merge
Jul 8, 2024
(Reuters) - Skydance Media and Paramount Global have agreed to a merger, the companies announced late on Sunday, marking the end of an era for the Redstone media empire which was launched as a chain of movie theaters by Shari Redstone's family in 1936. Originally named the Northeast Theater Corporation, it later morphed into National Amusements, which eventually became one...
Ideaya Biosciences Reports Positive Results for Potential Non-Small Cell Lung Cancer Treatment -- Shares Rise Pre-Bell
Ideaya Biosciences Reports Positive Results for Potential Non-Small Cell Lung Cancer Treatment -- Shares Rise Pre-Bell
Jul 8, 2024
06:57 AM EDT, 07/08/2024 (MT Newswires) -- Ideaya Biosciences ( IDYA ) said Monday it received positive clinical data in a phase 2 clinical trial of IDE397 in methylthioadenosine phosphorylase-deletion urothelial and non-small cell lung cancer patients. In the trial of 18 evaluable patients, 94% showed disease control and 78% showed tumor shrinkage. Ideaya's Chief Medical Officer Darrin Beaupre said...
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 billion
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 billion
Jul 8, 2024
(Reuters) -Eli Lilly ( LLY ) will acquire Morphic Holding ( MORF ) for $3.2 billion, the companies said on Monday, giving the U.S. drugmaker access to an experimental drug for inflammatory bowel disease. Shares of drug developer Morphic ( MORF ) surged 76% to $56.15 premarket on Lilly's offer of $57 per share, which represents a 79% premium to...
TIMELINE-End of Redstone era as Paramount, Skydance Media agree to merge
TIMELINE-End of Redstone era as Paramount, Skydance Media agree to merge
Jul 8, 2024
(Recasts paragraphs 1 to 4, adds deal agreement between Skydance and Paramount) July 8 (Reuters) - Skydance Media and Paramount Global ( PARAA ) have agreed to a merger, the companies announced late on Sunday, marking the end of an era for the Redstone media empire which was launched as a chain of movie theaters by Shari Redstone's family in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved